Nanograb is a biotechnology and computational drug discovery company developing AI-designed delivery systems for genetic medicines and targeted therapies. Its platform creates combinations of small peptide binders attached to nanoparticles, aiming to direct treatments to precise cells and tissues while reducing off-target effects. The company works in nanomedicine, drug delivery and therapeutics, with applications across areas such as cancer, neurological conditions, infectious disease and degenerative disorders. Nanograb’s services are centred on designing targeted, non-viral gene therapy vectors and partnering with biopharmaceutical organisations to improve the precision, safety and scalability of advanced medicines.
This is a company profile stub. Create an account to claim your profile.
Industry
BiotechnologyAreas of Focus
Status
Active
